The President of the European Commission, Ursula von der Leyen, arranged to block AstraZeneca’s exports of the coronavirus, if the block does not receive the first dose.
“We have the option to suspend exported exports. This is our message to AstraZeneca: Respect the contract with Europe before it starts to act [dosis] otros países “, says the person in charge in an interview with the German press group Funke.
Von der Leyen says that the British-Swedish laboratory AstraZeneca alone has contributed 30% of the 90 million vacant vacancies at the EU in the first quarter of this year.
The company argues that it has slowed down production in its European factories, according to European officials, not to mention its allegation against AstraZeneca that it will be registered with the United Kingdom for all doses.
El mircoles, Von der Leyen is responsible for restoring the conditions of carriage and export carts, through a question of “reciprocity” and “proportionality”.
“All options are based on the message”, says the person in charge.
“We are willing to take advantage of the fact that we are precisely in order to do so, and we will ensure that Europe has its fair share,” he added.
The President of the European Commission recorded that the EU contract with AstraZeneca prevailed over the production of doses as high as the EU as in the United Kingdom. “But we have not received anything from the British, just because the summitists”, argued Ursula von der Leyen, adding that the EU had sent a “formal card” to join the Swedish-British pharmaceutical group.
“I am able to explain to European citizens why we are exporting millions of vacancies to countries that produce them differently and do not develop any of them,” he added.
The European Union has once again adopted a mechanism for controlling the export of vacancies, and the week before the extension of the application of these standards until the end of June.
In view of this mechanism, companies that work with the EU on the prevention of vacancies should obtain an authorization to export the dose of the block.
In order to prohibit the export of the vacancies, the Member State where the producer must initiate the procedure and act securely, the Commission of its good visions.
This mechanism has been applied for some time, in the case of Italy, which blocked the export of a cargo of 250,000 doses of AstraZeneca pharma from Australia, arguing the “persistent escalation” of vacancies and the “retreats in the summit” by the laboratory.